|
|
||||||||
1 Unité 441 Athérosclérose and IFR 4, Institut National de la Santé et de la Recherche Médicale, 33600 Pessac, France; and 2 Department of Biochemistry and Molecular Biology, OGI School of Science and Engineering, Oregon Health & Sciences University, Beaverton, Oregon 97006
| |
ABSTRACT |
|---|
|
|
|---|
Diazoxide opening of the mitochondrial ATP-sensitive K+ (mitoKATP) channel protects the heart against ischemia-reperfusion injury by unknown mechanisms. We investigated the mechanisms by which mitoKATP channel opening may act as an end effector of cardioprotection in the perfused rat heart model, in permeabilized fibers, and in rat heart mitochondria. We show that diazoxide pretreatment preserves the normal low outer membrane permeability to nucleotides and cytochrome c and that these beneficial effects are abolished by the mitoKATP channel inhibitor 5-hydroxydecanoate. We hypothesize that an open mitoKATP channel during ischemia maintains the tight structure of the intermembrane space that is required to preserve the normal low outer membrane permeability to ADP and ATP. This hypothesis is supported by findings in mitochondria showing that small decreases in intermembrane space volume, induced by either osmotic swelling or diazoxide, increased the half-saturation constant for ADP stimulation of respiration and sharply reduced ATP hydrolysis. These effects are proposed to lead to preservation of adenine nucleotides during ischemia and efficient energy transfer upon reperfusion.
mitochondria; metabolism; creatine kinase; membrane transport; cytochrome c; ischemic preconditioning
| |
INTRODUCTION |
|---|
|
|
|---|
THERE IS NOW GENERAL AGREEMENT that the mitochondrial ATP-sensitive K+ (mitoKATP) channel plays a pivotal role in cardioprotection against ischemia-reperfusion injury (16, 17, 20, 21, 36, 64); however, little is known about the mechanism of this protection. It has been proposed that mitoKATP channel opening triggers protection by increasing the generation of reactive oxygen species (ROS) (13, 47), and this effect has now been demonstrated by several laboratories (10, 13, 44, 57). We proposed that the mitoKATP channel is also an end effector of protection (16), and many studies have confirmed that the mitoKATP channel is required to be open during the ischemic phase (11, 46, 58, 59, 64). Thus the mitoKATP channel is both a trigger and an end effector of cardioprotection, and these two roles are temporally and mechanistically distinct.
We have previously suggested that cardioprotection by mitoKATP channel opening is due in part to volume regulation, which serves to preserve the structure-function of the intermembrane space (IMS) and the low permeability of the outer membrane to nucleotides (31). Nucleotide transport across the outer membrane occurs primarily through the voltage-dependent anion channel (VDAC) (2, 34, 49, 50). We hypothesize that VDAC permeability to nucleotides is regulated in part by IMS volume, which in turn is regulated by K+ flux across the inner membrane.
This study focuses on the end effector mechanisms by which an open mitoKATP channel protects the heart during ischemia and reperfusion. We show, in saponin-skinned rat heart fibers, that diazoxide, like ischemic preconditioning (IPC) (31), prevents ischemia-induced alterations in mitochondrial function, which include increased outer membrane permeability to nucleotides and cytochrome c (cytC). Studies on isolated mitochondria and saponin-skinned fibers strongly support the hypothesis that increasing matrix volume, due to mitoKATP channel opening, reduces the permeability of VDAC to nucleotides. The consequences of this effect are 1) to reduce the rate of ATP hydrolysis during ischemia, thereby preserving total adenine nucleotide content, and 2) to permit efficient energy transformation upon reperfusion, thereby preventing mitochondrial ROS production and irreversible damage to mitochondria.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Langendorff perfusion. Male Sprague-Dawley rats weighing 350-375 g were anesthetized with 40 mg pentobarbital sodium injected intraperitoneally. The thorax was opened, and hearts were rapidly excised, immediately cooled in iced Krebs buffer, and perfused by an aortic canula delivering 37°C buffer at a constant pressure of 100 mmHg. Hearts were perfused with a modified phosphate-free Krebs-Henseleit solution containing (in mM) 118 NaCl, 5.9 KCl, 1.75 CaCl2, 1.2 MgSO4, 0.5 EDTA, 25 NaHCO3, and 16.7 glucose. The high glucose concentration was employed to overcome possible limitations of glucose uptake by the cardiomyocytes. The perfusate was gassed with 95% O2-5% CO2, which resulted in a PO2 above 600 mmHg at the level of the aortic canula and a buffer pH of 7.4. The pulmonary artery was transected to facilitate coronary venous drainage, and a left ventricular polyethylene apical drain was inserted through a left atrial incision to allow Thebesien venous drainage. Left ventricular pressure was monitored from a water-filled latex balloon placed through the left atrial appendage and connected to a pressure transducer. The volume of the balloon was adjusted to obtain a left ventricular diastolic pressure of 7 mmHg and kept constant throughout the entire experiment. Hearts were not paced and mechanical performance was evaluated as the product of heart rate and developed pressure (RPP).
Perfusion protocols. Four groups of hearts were studied (n = 6 in each group). The control group was perfused under well-oxygenated conditions for 85 min. The ischemia-reperfusion group was perfused under well-oxygenated conditions for 40 min, subjected to 30-min zero-flow ischemia, and then reperfused for 15 min. For the diazoxide group, 100 µM diazoxide was added to the perfusate 20 min before ischemia. For the diazoxide + 5 hydroxydecanoate (5-HD) group, 100 µM diazoxide and 300 µM 5-HD were added to the perfusate 20 min before ischemia. Diazoxide and 5-HD were not added to the perfusate during reperfusion.
Permeabilized cardiac fibers. Mitochondrial function was assessed on permeabilized skinned fibers of the left ventricle obtained immediately at the end of the perfusion protocols. An additional group of hearts was studied immediately after excision of the organ without prior perfusion (in situ group, n = 6). Preparation of permeabilized cardiac fibers has been extensively described (28, 30, 54, 61). Briefly, small pieces of cardiac muscle were taken from the left ventricle and put into cold solution A (see below). They were rapidly dissected into bundles of fibers and incubated for 30 min with shaking in 1.8 ml solution A in the presence of 50 µg/ml saponin to selectively permeabilize the sarcolemma. The bundles were subsequently put in solution B twice for 10 min to wash out adenine nucleotides, phosphocreatine (PCr), and saponin. Respiration of skinned fibers (0.5-0.75 mg dry wt) was measured at 25°C using a Clark electrode in an oxygraphic cell containing either 2 ml solution B supplemented with 10 mM pyruvate, 5 mM malate, and 1 mg/ml BSA or 2 ml KCl solution. The solubility of oxygen was assumed to be 215 nmol O2/ml. Additional experiments were performed on control fibers before and after addition of 8 nM nigericin, a K+/H+ antiporter. For these experiments, oxygraphic measurements were performed in solution B without BSA.
Solution A contained (in mM) 2.77 CaK2EGTA, 7.23 K2EGTA (pCa = 7), 6.56 MgCl2, 0.5 dithiothreitol (DTT), 50 K-MES, 20 imidazole, 20 taurine, 5.3 Na2ATP, and 15 PCr. pH = 7.1 and was adjusted at 25°C. Solution B contained (in mM) 2.77 CaK2EGTA, 7.23 K2EGTA (pCa =7), 1.38 MgCl2, 0.5 DTT, 50 K-MES, 20 imidazole, 20 taurine, and 3 KH2PO4. pH = 7.1 and was adjusted at 25°C. KCl solution contained (in mM) 125 KCl, 20 HEPES, 10 pyruvate, 5 malate, 3 Mg acetate, 5 KH2PO4, 0.4 EGTA, and 0.3 DTT. pH = 7.1 and was adjusted at 25°C, and 2 mg/ml BSA was added.Assessment of outer membrane permeability to cytC. State 2 respiration of skinned cardiac fibers was measured in KCl solution, and respiration was then stimulated by the addition of 1 mM ADP, which induced a maximum activation of respiration (state 3). cytC was added at a final concentration of 8 µM. In KCl medium, endogenous cytC dissociates from the outer surface of the inner mitochondrial membrane, but continues to support maximal respiration as long as the outer membrane retains its impermeability to cytC (6, 24). In this condition, addition of exogenous cytC will have no effect on respiration. If the outer membrane has become permeable to cytC, some cytC will be lost from mitochondria, and addition of cytC will increase the respiratory rate (6, 28, 31).
Determination of the half-saturation constant of ADP. Respiration of skinned cardiac fibers was measured in solution B containing pyruvate and malate. Increasing amounts of ADP ranging from 0.0125 to 1 mM were successively added. The stimulatory effect of ADP was calculated from respiration rates measured in the presence of ADP minus the value in the absence of ADP (state 2). The half-saturation constant for ADP [K1/2 (ADP)] was calculated from double-reciprocal plots of respiration versus ADP concentration in the presence and absence of 20 mM creatine (Cr).
Bioenergetic studies on isolated rat heart mitochondria. Rat heart mitochondria were isolated by differential centrifugation from the hearts of three to four Wistar strain rats, as described by Kay et al. (27). Unless specified, respiration experiments were conducted at 30°C in solution B. K-MES concentrations were varied to obtain different osmolalities. K1/2 (ADP) was determined as described for skinned fibers. Hexokinase (0.01 U/ml) and 1 mM glucose were present in all incubations to consume ATP generated by mitochondria (54).
ATP hydrolysis was determined using a luciferin/luciferase photodynamic system (35). Mitochondrial suspensions (0.5 mg/ml) were incubated for 90 s in solution B supplemented with 2 µM antimycin A and 200 µM ATP, after which ATP hydrolysis was stopped by the addition of oligomycin (2 µg/ml) and samples were frozen in liquid nitrogen. Mitochondria were thawed, the membranes were pelleted at 10,000 g for 2 min, and the ATP remaining in the supernatant was determined. Light emission was integrated for 60 s, 15 s after the addition of 187.5 µg/ml luciferin/luciferase (Sigma). Total ATP was determined in control preparations pretreated with oligomycin, and the results are expressed as the percent ATP remaining. Mitochondrial membrane potentials (
) were determined from the
fluorescence changes of safranin O at excitation and emission wavelengths of 495 and 586 nm, respectively. Calibration was performed through K+ distribution in a K+-free,
tetraethylammonium ion-based media, as previously described (1).
Measurements of mitochondrial volume. Matrix volume was manipulated by varying osmolality or by adding diazoxide. IMS volume was further manipulated by adding polyethylene glycol (PEG)-8000 (10% wt/vol), to which the outer membrane is impermeable (18). Medium osmolalities were determined from freezing point depression. Changes in matrix volume, which accompany net salt transport across the inner membrane, were followed using a quantitative light-scattering technique calibrated to mitochondrial matrix water content. This technique is based on the principle that reciprocal absorbance of the mitochondrial suspension, when corrected for the extrapolated absorbance at infinite protein concentration, is linearly related to matrix volume within well-defined regions, as described in detail by Beavis et al. (5). The osmolality at which the outer membrane begins to break was also determined from light-scattering measurements as previously described (5). Matrix water content (in µlH2O/mg protein) was determined in parallel experiments as sucrose-free pellet water, as previously described (5).
Statistical analysis of experimental data. Data are expressed as means ± SE. A two-way ANOVA for repeated measurements was performed to analyze hemodynamic parameters at different time points and under different experimental conditions. Single-factor ANOVA followed by an unpaired Student's t-test of the means was used to investigate respiration parameters. A value of P < 0.05 was considered statistically significant.
| |
RESULTS |
|---|
|
|
|---|
Hemodynamic data.
The results in Fig. 1 show that the
control hearts were stable, with constant diastolic pressure and <15%
decrease in RPP over the 85-min perfusion period. Ischemia
resulted in cardiac arrest. Ischemic contracture was observed
after 10 min of ischemia with a maximum of 63 ± 4 mmHg
(P < 0.001) measured after 25 min of ischemia.
After 15 min of reperfusion, only 4% recovery of systolic
function was observed, with a maximum RPP of 1,400 ± 800 mmHg · beats · min
1 (P < 0.001). These data show the early occurrence of contracture during ischemia and a poor early recovery of systolic function after reperfusion.
|
1 (P < 0.01 vs. the ischemic group). Despite the absence of
ischemic contracture, a significant increase of left
ventricular diastolic pressure was observed upon reperfusion. Overall,
these data show that diazoxide completely prevented ischemic
contracture and significantly improved postischemic recovery of
systolic function. These cardioprotective effects were abolished when
300 µM 5-HD was included with the diazoxide. Ischemic
contracture was similar to that observed in the
ischemia-reperfusion group, and recovery of RPP upon
reperfusion was significantly decreased compared with the diazoxide
group (9,000 ± 2,000 mmHg · beats · min
1, P < 0.05).
Permeability of the outer mitochondrial membrane to cytC.
We measured the effect of 8 µM exogenous cytC on the maximal rate of
respiration determined at 1 mM ADP, as described in MATERIALS AND
METHODS, with the results shown in Fig.
2. Maximal respiration in situ and in
perfused control groups was 31 ± 4 and 31 ± 3 nmol O2 · min
1 · mg dry
wt
1, respectively, and neither group was stimulated by
cytC. There was a small increase in state 2 respiration in perfused
versus in situ controls hearts (10.4 and 7.7 nmol
O2 · min
1 · mg dry
wt
1, respectively, P = 0.15); however,
respiration after inhibition of the ADP-stimulated respiration by
oligomycin (15 µM) and atractyloside (13 µM) were the same in both
control groups (data not shown). Thus the perfusion protocol per se did
not significantly modify respiratory function or outer membrane
permeability to cytC.
|
Regulation of respiration of permeabilized cardiac fibers by ADP
and Cr.
The data shown in Fig. 3 contain
K1/2 (ADP) values determined from double
reciprocal plots in the presence or absence of Cr, as described in
MATERIALS AND METHODS. In in situ and perfused control
hearts, K1/2 (ADP) values were 395 ± 75 and 327 ± 45 µM, respectively [not significant (NS)]. In the
presence of Cr, these values decreased to 65 ± 23 and 85 ± 24 µM, respectively (NS). This is due to the presence in the IMS of
the mitochondrial isoform of creatine kinase (Mi-CK), which rapidly
phosphorylates Cr with freshly synthesized ATP. The ADP formed returns
to the matrix, and the creatine phosphate is exported to the cytosol.
|
Osmotic behavior of mitochondria.
The mitochondrial inner membrane is highly permeable to water, and
mitochondria therefore behave as osmometers, responding instantly to a
change in the osmotic strength of the medium (14). The
osmotic curves shown in Fig. 4 were
obtained from rat heart mitochondria using two different techniques:
radioisotope distribution to measure matrix volume and light scattering
to estimate total particle volume (5). The data shown in
Fig. 4 are qualitatively the same as those obtained previously for rat
liver mitochondria (5), and we interpret the results in
the same way. The osmotic curve for matrix volume is linear over the
entire range, and it is also reversible (data not shown). In contrast,
the osmotic curve for total volume is segmentally linear and exhibits a
sharp transition at 149 ± 2 mosM (n = 3), or 1.9 µl matrix H2O/mg mitochondrial protein. At osmolalities
higher than 149 mosM, this osmotic curve is also reversible in both
liver (5) and heart (data not shown) mitochondria. Stoner
and Sirak (56) showed that matrix swelling-contraction in
this isosmotic range occurs at the expense of the IMS. The transition
at 149 mosM occurs when matrix volume exceeds that which can be
contained within the outer mitochondrial membrane and reflects the
volume at which the outer membrane begins to rupture due to excessive
matrix swelling (5). As expected, the light scattering
osmotic curve is no longer reversible after the outer membrane breaks
(5).
|
|
Effects of mitoKATP channel openers and blockers on
matrix volume.
Figure 6A shows the changes in
steady-state matrix volume due to opening and closing
mitoKATP channels in isolated rat heart mitochondria.
It can be seen that diazoxide caused a 15-20% increase in
steady-state volume, and this effect was blocked by 5-HD. We have found
that diazoxide has little effect on respiration, membrane potential, or
Ca2+ uptake in isolated mitochondria due to the relatively
low K+ flux catalyzed by mitoKATP channels
(29); however, Marban and co-workers (36, 39)
propose that mitoKATP channel opening in vivo causes
sufficient K+ cycling to uncouple mitochondria, leading to
reduced Ca2+ uptake and cardioprotection. While this issue
remains unresolved, our conclusion that the increased K+
cycling caused by mitoKATP channel opening is insufficient
to cause uncoupling (29) is supported by a variety of in
vivo and in situ studies: Standen and co-workers (33)
observed diazoxide cardioprotection in cardiomyocytes with no
detectable change in FAD fluorescence or in mitochondrial 
.
Carroll et al. (7) observed diazoxide-induced
mitochondrial swelling without effects on 
in human atrial cells.
Grover et al. (22, 23) showed that cardioprotective
concentrations of KATP channel openers have no effect on
the cardiac efficiency of oxygen utilization in the intact heart, which
appears to exclude significant uncoupling. Ventura-Clapier and
co-workers (45) showed that moderate doses of diazoxide
had no detectable bioenergetic effects in permeabilized fibers.
|
Effects of matrix and IMS volumes on oxidative phosphorylation in
heart mitochondria.
The K1/2 (ADP) is strongly influenced by outer
membrane permeability to ADP. Saks et al. (52, 54) have
shown that isolated mitochondria have a high affinity for ADP, with
K1/2 (ADP) ~20 µM, whereas the value in
situ is much higher, ~250 µM. We undertook to determine whether
this difference may arise in part from the artifactual contraction of
the matrix (and expansion of the IMS) caused by isolation (Fig. 5).
Indeed, the K1/2 (ADP), determined as
illustrated in Fig. 7, was found to
increase significantly as a result of a small change in medium
osmolality. Decreasing medium osmolality from 243 to 212 mosM caused
K1/2 (ADP) to increase from 17.1 to 71.3 µM
(Fig. 8A, open bars). When
osmolality was decreased below the point of outer membrane rupture,
K1/2 (ADP) returned to the level observed with
contracted mitochondria. After outer membrane rupture, the
K1/2 (ADP) was no longer affected by changes in
osmolality in the 145-243 mosM range (data not shown). In these
experiments, mitochondria are taking up K+ salts and water
rapidly during the 1-2 min of incubation before the first addition
of ADP, and therefore the outer membrane will rupture at higher
osmolalities than those observed in the equilibrium experiments shown
in Fig. 4. We believe that this accounts for the finding that the
volume effect shown in Fig. 8A reached a maximum at 212 mosM. Diazoxide also caused an increase in K1/2 (ADP) (Fig. 8A, hatched bars), and this effect was additive
with hypotonic swelling until a maximum was achieved at 85 ± 3 µM. These results demonstrate that restoration of matrix and IMS
volumes results in lower affinity for ADP, reflecting a restoration of the low nucleotide permeability of the outer membrane.
|
|
|
Effects of volume on ATP hydrolysis in ischemic heart
mitochondria.
Given that volume regulation strongly affects outer membrane
permeability to ADP (Figs. 8 and 9) and that mitoKATP
channels can regulate mitochondrial volume even under conditions of
ischemia (Fig. 6B), we hypothesized that volume
regulation should also affect ATP compartmentation and hydrolysis
during ischemia. The data shown in Fig.
10 summarize an extensive series of
measurements of ATP hydrolysis by nonrespiring mitochondria. Moderate
reductions in osmolality, with consequent IMS contraction, caused
profound reductions in ATP hydrolysis. At 243 mosM, diazoxide reduced
ATP hydrolysis by ~45%. At 212 mosM, diazoxide caused a nearly 90% reduction in ATP hydrolysis compared with controls. ATP hydrolysis returned to control values after outer membrane rupture, which resulted
in complete loss of the volume sensitivity of ATP hydrolysis (data not
shown). As stated in connection with the experiments shown in Fig.
8A, we interpret the finding that ATP hydrolysis reached a
minimum at 212 mosM as being due to the fact that both hypotonicity and
uptake of K+ salts and water are taking place
simultaneously, causing the outer membrane to rupture at higher
osmolalities than those observed in the equilibrium experiments shown
in Fig. 4. From these studies, we draw conclusions similar to those
relating to the volume effect on K1/2 (ADP):
1) opening mitoKATP channels reduces ATP
hydrolysis, 2) this effect is due to small changes in matrix
volume, and 3) an intact outer membrane is necessary for the
effect.
|

itself, we measured 
supported either by respiration (Fig. 10B, open bars) or by ATP hydrolysis in the presence of a
respiratory chain inhibitor (Fig. 10B, hatched bars). We
observed that osmotic swelling of mitochondria had no effect on 
supported by respiration; however, it caused a profound decrease of

supported by ATP hydrolysis. On this basis, we conclude that
restoration of matrix volume causes a depolarization of 
, which
reduces the inner membrane proton leak that is responsible for ATP
hydrolysis. The mechanism of this effect is addressed in the
DISCUSSION.
| |
DISCUSSION |
|---|
|
|
|---|
This study confirms previous work (16) showing that diazoxide treatment of Langendorff-perfused rat hearts before ischemia improves recovery of cardiac function after reperfusion, delays the onset of contracture, and decreases the amplitude of contracture. The hypothesis that the mitoKATP channel is the receptor for the cardioprotective actions of KATP channel openers (17) implies that important aspects of protection occur at the mitochondrial level. Our studies on permeabilized fibers reveal three components of mitochondrial protection by diazoxide: 1) reduced permeability to exogenous cytC (Fig. 2); 2) maintenance of low outer membrane permeability to nucleotides, reflected in the high values of K1/2 (ADP) in the regulation of respiration (Fig. 3); and 3) preservation of functional coupling between the ATP/ADP translocator and Mi-CK, reflected in the increased affinity for ADP in the presence of Cr (Fig. 3). The same components of mitochondrial protection were previously described for IPC (31).
To understand these effects, it is necessary to consider the complex
sequence of events that follow diazoxide administration. MitoKATP channel opening in the resting state of the
cardiomyocyte, in which oxygen consumption is low and 
is high,
will cause a modest increase in mitochondrial K+ influx and
matrix expansion, as shown in Fig. 6A. As we have previously
reported (13), the K+ influx causes a moderate
increase in mitochondrial production of ROS, which, in turn triggers
the cardioprotective signaling pathway (47). The
observation that mitoKATP channel opening induces ROS
production has now been reported by several laboratories (7, 10,
44, 57). We have proposed a mechanism for this effect
(3) and will address this aspect in more detail in future communications.
We hypothesize that the cardioprotective signaling pathway causes two changes in mitochondria, perhaps by phosphorylating mitochondrial proteins: the outer membrane retains its impermeability to cytC and the mitoKATP channel is opened. It has been proposed that disruption of contact sites between inner and outer membranes promotes cytC release (9), suggesting that mitoKATP channel opening may mediate this protective effect by preventing contact site disruption. However, it is equally likely that the prevention of cytC release occurs by independent mechanisms. Outer membrane permeability to cytC is known to be controlled by the Bcl-2 family of proteins (65), and there is evidence that translocation of activated Raf-1 to mitochondria protects the cells from apoptosis via regulation of Bcl-2 activity (42, 43, 48) and also that phosphorylation of proapoptotic Bid prevents apoptosis (8). One or both of these mechanisms may be triggered independently by the cardioprotective signaling pathway. We propose that cell signaling causes mitoKATP channels to be open during ischemia, so that it can act an end effector of cardioprotection (16). Pain et al. (47) have questioned the end effector role of mitoKATP channels based on the finding that 5-HD administered 5 min before the test ischemia failed to block diazoxide protection. However, Wang et al. (64) found that a higher dose of 5-HD was required at this stage and that 5-HD did block protection when administered after diazoxide washout. Indeed, many studies show that the mitoKATP channel is required to be open during the ischemic phase (11, 46, 58, 59, 64). The results of a recent study by Tsuchida et al. (59) are particularly convincing in this regard. They show that diazoxide reduced infarct size even when administered after the onset of ischemia, provided that diazoxide was added before the development of necrosis. Several studies indicate that infarct size is reduced even when the mitoKATP channel is opened at the time of reperfusion (38, 58, 60).
There is evidence that IPC and K+ channel openers
specifically protect mitochondrial function during ischemia.
Protected hearts exhibit a reduced rate of ATP loss during
ischemia (22, 37, 40). Mitochondrial 
is
lower during ischemia, leading to reduced Ca2+
accumulation (63, 67), which has been identified as being important for cardioprotection (25, 36). Jennings et al.
(26) have shown that adenine nucleotides are rapidly
degraded during ischemia and that IPC retards the rate of
degradation. This may be particularly important, because the
cardiomyocyte cannot survive reperfusion if there is no ADP available
to phosphorylate.
To explain these effects, we hypothesize that mitoKATP channel opening preserves the segregation of adenine nucleotides that normally exists between the mitochondrial and cytosolic compartments. Nucleotide permeability is controlled by VDAC, which is normally in a low conductance state that is poorly permeable to ATP (2, 34, 50), and energy transfers between mitochondria and cytosol are mediated instead by Cr and creatine phosphate (55). Octamers of Mi-CK bridge the IMS between outer membrane VDAC and inner membrane ATP/ADP translocator (62). We hypothesize that binding of octameric Mi-CK to VDAC confers a low conductance to nucleotides and that this binding requires a narrow intermembrane distance. When IMS expands due to matrix contraction, Mi-CK dissociates from VDAC, leading to a high conductance state.
Two measurements that reflect outer membrane permeability to nucleotides are the K1/2 (ADP) for respiration (31) and the rate of ATP hydrolysis in nonrespiring mitochondria. The data shown in Figs. 7-10 show for the first time that changes in matrix volume have profound effects on both of these parameters and that an intact outer membrane is required for these effects. Diazoxide caused a massive reduction in the rate of ATP hydrolysis in rat heart mitochondria undergoing simulated ischemia (Fig. 10) and a large increase in K1/2 (ADP) (Fig. 8). The effects of matrix volume on K1/2 (ADP) were confirmed in skinned, intact cardiac fibers, in which a very low dose of nigericin, to contract the matrix and expand the IMS, caused a 70% drop in the K1/2 (ADP) (Fig. 9). Finally, we show that ischemia causes a profound decrease in K1/2 (ADP) in fibers after ischemia-reperfusion and that diazoxide prevents this loss of nucleotide compartmentation (Fig. 3A).
In order for mitoKATP channels to play a role during ischemia, it is necessary to postulate that the matrix contracts (and IMS expands) during the initial stages of ischemia and that mitoKATP channel opening prevents these volume changes. There is no direct experimental evidence for matrix contraction during early ischemia, but it must be noted that a 10% contraction may be too small to detect. Moreover, electron microscopic studies have generally focused on matrix swelling, which we view as a later, pathological event occuring in nonprotected cells. There are theoretical and experimental grounds for postulating ischemia-induced matrix contraction: mitochondria will depolarize due to lack of oxygen, causing a decrease in diffusive K+ influx. Matrix volume will therefore contract until the K+/H+ antiporter is sufficiently inhibited to bring influx and efflux into balance, at which time matrix volume will achieve a new steady state at lower levels. These changes have been demonstrated in isolated heart mitochondria, as shown in Fig. 6B and Ref. 29. Therefore, we propose that an open mitoKATP channel during ischemia, by virtue of its role in regulating matrix and IMS volumes, conserves cellular adenine nucleotides by preserving the normal low conductance state of VDAC.
The mechanism of the volume-dependent decrease in ATP hydrolysis
requires further scrutiny. ATP hydrolysis is determined by the rate of
ion leaks (primarily of protons) across the inner membrane. Ion leaks,
in turn, depend on 
(15), and 
is in equilibrium with the free energy of ATP hydrolysis
(
GP). Consequently, the extent of ATP loss at
any given time during ischemia will depend on
GP, and the only way to reduce
Ca2+ uptake and ATP hydrolysis during ischemia is
to lower mitochondrial
GP to a greater
extent than cytosolic
GP. This is not
possible when VDAC are in their high conductance state, because
nucleotides are then in equilibrium across the outer membrane. When
mitoKATP channels are open, however, major
perturbations in matrix and IMS volumes are prevented (Fig.
6B). The structure-function of the IMS is preserved, and
VDAC will be maintained in the low conductance state. Nucleotides will
not equilibrate across the outer membrane, and ATP hydrolysis will lead
to accumulation of ADP and loss of ATP from the IMS. This will decrease
mitochondrial
GP and 
, causing
reduced proton leak and, consequently, a decreased rate of ATP
hydrolysis. This mechanism is confirmed by the finding that 
declined much more rapidly when ATP hydrolysis was inhibited by mild
matrix swelling (Fig. 10B). (It should be noted that the simultaneous decline of 
and ATP hydrolysis excludes uncoupling as a cause of the decline in 
.) According to this hypothesis, the
ability of mitoKATP channel opening to reduce ATP
hydrolysis derives from segregation of ATP and
GP between the mitochondrial and external compartments.
These findings support a plausible mechanism by which
mitoKATP channel opening during ischemia
1) reduces the rate of ATP loss (22, 37, 40),
2) reduces the rate of adenine nucleotide degradation so
that ADP is available for phosphorylation upon reperfusion
(26), and 3) reduces 
and
Ca2+ accumulation (63, 67). These effects
preserve mitochondria so that, upon reperfusion, they can return to
their normal function of providing adequate ATP supply to cytosolic ATPases.
We suggest that the rapid recovery of high-energy phosphates
after reperfusion of IPC or diazoxide-treated hearts is again due to
segregation of mitochondrial
GP. When
VDAC are open after ischemia-reperfusion, respiration will be
controlled by cytosolic ADP concentration, and restriction of ADP
diffusion in the cytosol will result in a limitation of ATP production
(54), worsening ischemia-induced damage to the
cardiomyocyte. When VDAC are closed in the protected myocyte,
reoxygenation will enable mitochondrial ADP to be phosphorylated and
the resulting ATP to be converted immediately within the IMS to
creatine phosphate, which is then exported to the cytosol (51,
53). In this way, preservation of IMS structure-function during
ischemia will lead to a fully functional Mi-CK system upon
reperfusion, thereby preparing the heart for resumption of normal function.
In summary, opening of mitoKATP channels by diazoxide
triggers the cardioprotective signaling pathway by inducing ROS
production. One molecular consequence of this pathway is to open
mitoKATP channels, which serves to retard the rate of ATP
hydrolysis secondary to volume-dependent segregation of
GP by the outer membrane. Upon
reperfusion, preservation of ADP and mitochondrial structure permits
efficient energy transfer between mitochondria and the cytosol. These
effects are mediated by the volume regulatory actions of
mitoKATP channels, which preserve the structure function of the IMS, and, in particular, maintain the normal low permeability of
the mitochondrial outer membrane to nucleotides.
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported by research grants from Pôle Médicament Aquitaine (to P. Dos Santos), National Institute for General Medical Sciences Grant GM-55324 (to K. D. Garlid), and American Heart Association Grant 0140138N (to P. Paucek)
| |
FOOTNOTES |
|---|
Present address of A. J. Kowaltowski: Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, SP, Brazil.
Address for reprint requests and other correspondence: K. D. Garlid, Dept. of Biochemistry and Molecular Biology, OGI School of Science and Engineering, Oregon Health & Sciences Univ., 20000 NW Walker Rd., Beaverton, OR 97006-8921 (E-mail: garlid{at}bmb.ogi.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
First published February 14, 2002;10.1152/ajpheart.00034.2002
Received 16 January 2002; accepted in final form 11 February 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Akerman, KE,
and
Wikstrom MK.
Safranine as a probe of the mitochondrial membrane potential.
FEBS Lett
68:
191-197,
1976[ISI][Medline].
2.
Anflous, K,
Armstrong DD,
and
Craigen WJ.
Altered mitochondrial sensitivity for ADP and maintenance of creatine-stimulated respiration in oxidative striated muscles from VDAC1-deficient mice.
J Biol Chem
276:
1954-1960,
2001
3.
Bajgar, R,
Seetharaman S,
Kowaltowski AJ,
Garlid KD,
and
Paucek P.
The ATP-sensitive potassium channel of brain mitochondria and its possible role in ischemia-reperfusion injury.
J Biol Chem
276:
33369-33374,
2001
4.
Bakeeva, LE,
Chentsov Yu S,
and
Skulachev VP.
Mitochondrial framework (reticulum mitochondriale) in rat diaphragm muscle.
Biochim Biophys Acta
501:
349-369,
1978[Medline].
5.
Beavis, AD,
Brannan RD,
and
Garlid KD.
Swelling and contraction of the mitochondrial matrix. I. A structural interpretation of the relationship between light scattering and matrix volume.
J Biol Chem
260:
13424-13433,
1985
6.
Borutaite, V,
Morkuniene R,
Budriunaite A,
Krasauskaite D,
Ryselis S,
Toleikis A,
and
Brown GC.
Kinetic analysis of changes in activity of heart mitochondrial oxidative phosphorylation system induced by ischemia.
J Mol Cell Cardiol
28:
2195-2201,
1996[ISI][Medline].
7.
Carroll, R,
Gant VA,
and
Yellon DM.
Mitochondrial KATP channel opening protects a human atrial-derived cell line by a mechanism involving free radical generation.
Cardiovasc Res
51:
691-700,
2001
8.
Desagher, S,
Osen-Sand A,
Montessuit S,
Magnenat E,
Vilbois F,
Hochmann A,
Journot L,
Antonsson B,
and
Martinou J.
Phosphorylation of bid by casein kinases i and ii regulates its cleavage by caspase 8.
Mol Cell
8:
601-611,
2001[ISI][Medline].
9.
Doran, E,
and
Halestrap AP.
Cytochrome c release from isolated rat liver mitochondria can occur independently of outer-membrane rupture: possible role of contact sites.
Biochem J
348:
343-350,
2000[Medline].
10.
Forbes, RA,
Steenbergen C,
and
Murphy E.
Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism.
Circ Res
88:
802-809,
2001
11.
Fryer, RM,
Hsu AK,
and
Gross GJ.
Mitochondrial KATP channel opening is important during index ischemia and following myocardial reperfusion in ischemic preconditioned rat hearts.
J Mol Cell Cardiol
33:
831-834,
2001[ISI][Medline].
12.
Garlid, KD.
On the mechanism of regulation of the mitochondrial K+/H+ exchanger.
J Biol Chem
255:
11273-11279,
1980
13.
Garlid, KD.
Opening mitochondrial KATP in the heart-what happens, and what does not happen.
Basic Res Cardiol
95:
275-279,
2000[ISI][Medline].
14.
Garlid, KD.
The state of water in biological systems.
Int Rev Cytol
192:
281-302,
2000[ISI][Medline].
15.
Garlid, KD,
Beavis AD,
and
Ratkje SK.
On the nature of ion leaks in energy-transducing membranes.
Biochim Biophys Acta
976:
109-120,
1989[Medline].
16.
Garlid, KD,
Paucek P,
Yarov-Yarovoy V,
Murray HN,
Darbenzio RB,
D'Alonzo AJ,
Lodge NJ,
Smith MA,
and
Grover GJ.
Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection.
Circ Res
81:
1072-1082,
1997
17.
Garlid, KD,
Paucek P,
Yarov-Yarovoy V,
Sun X,
and
Schindler PA.
The mitochondrial KATP channel as a receptor for potassium channel openers.
J Biol Chem
271:
8796-8799,
1996
18.
Gellerich, FN,
Kapischke M,
Kunz W,
Neumann W,
Kuznetsov A,
Brdiczka D,
and
Nicolay K.
The influence of the cytosolic oncotic pressure on the permeability of the mitochondrial outer membrane for ADP: implications for the kinetic properties of mitochondrial creatine kinase and for ADP channelling into the intermembrane space.
Mol Cell Biochem
133-134::
85-104,
1994[Medline].
19.
Gellerich, FN,
Wagner M,
Kapischke M,
Wicker U,
and
Brdiczka D.
Effect of macromolecules on the regulation of the mitochondrial outer membrane pore and the activity of adenylate kinase in the inter-membrane space.
Biochim Biophys Acta
1142:
217-227,
1993[Medline].
20.
Gross, GJ,
and
Fryer RM.
Sarcolemmal versus mitochondrial ATP-sensitive K+ channels and myocardial preconditioning.
Circ Res
84:
973-979,
1999
21.
Grover, GJ,
and
Garlid KD.
ATP-Sensitive potassium channels: a review of their cardioprotective pharmacology.
J Mol Cell Cardiol
32:
677-695,
2000[ISI][Medline].
22.
Grover, GJ,
Newburger J,
Sleph PG,
Dzwonczyk S,
Taylor SC,
Ahmed SZ,
and
Atwal KS.
Cardioprotective effects of the potassium channel opener cromakalim: stereoselectivity and effects on myocardial adenine nucleotides.
J Pharmacol Exp Ther
257:
156-162,
1991
23.
Grover, GJ,
Sleph PG,
Dzwonczyk S,
Malone HJ,
and
Behling RW.
Glyburide-reversible cardioprotective effects of BMS-180448: functional and energetic considerations.
J Cardiovasc Pharmacol
29:
28-38,
1997[ISI][Medline].
24.
Hackenbrock, CR,
Chazotte B,
and
Gupte SS.
The random collision model and a critical assessment of diffusion and collision in mitochondrial electron transport.
J Bioenerg Biomembr
18:
331-368,
1986[ISI][Medline].
25.
Jahangir, A,
Ozcan C,
Holmuhamedov EL,
and
Terzic A.
Increased calcium vulnerability of senescent cardiac mitochondria: protective role for a mitochondrial potassium channel opener.
Mech Ageing Dev
122:
1073-1086,
2001[ISI][Medline].
26.
Jennings, RB,
Sebbag L,
Schwartz LM,
Crago MS,
and
Reimer KA.
Metabolism of preconditioned myocardium: effect of loss and reinstatement of cardioprotection.
J Mol Cell Cardiol
33:
1571-1588,
2001[ISI][Medline].
27.
Kay, L,
Li Z,
Mericskay M,
Olivares J,
Tranqui L,
Fontaine E,
Tiivel T,
Sikk P,
Kaambre T,
Samuel JL,
Rappaport L,
Usson Y,
Leverve X,
Paulin D,
and
Saks VA.
Study of regulation of mitochondrial respiration in vivo. An analysis of influence of ADP diffusion and possible role of cytoskeleton.
Biochim Biophys Acta
1322:
41-59,
1997[Medline].
28.
Kay, L,
Rossi A,
and
Saks V.
Detection of early ischemic damage by analysis of mitochondrial function in skinned fibers.
Mol Cell Biochem
174:
79-85,
1997[ISI][Medline].
29.
Kowaltowski, AJ,
Seetharaman S,
Paucek P,
and
Garlid KD.
Bioenergetic consequences of opening the ATP-sensitive K+ channel of heart mitochondria.
Am J Physiol Heart Circ Physiol
280:
H649-H657,
2001
30.
Kunz, WS,
Kuznetsov AV,
and
Gellerich FN.
Mitochondrial oxidative phosphorylation in saponin-skinned human muscle fibers is stimulated by caffeine.
FEBS Lett
323:
188-190,
1993[ISI][Medline].
31.
Laclau, MN,
Boudina S,
Thambo JB,
Tariosse L,
Gouverneur G,
Bonoron-Adele S,
Saks VA,
Garlid KD,
and
Dos Santos P.
Cardioprotection by ischemic preconditioning preserves mitochondrial function and functional coupling between adenine nucleotide translocase and creatine kinase.
J Mol Cell Cardiol
33:
947-956,
2001[ISI][Medline].
32.
Laterveer, FD,
Nicolay K,
and
Gellerich FN.
ADP delivery from adenylate kinase in the mitochondrial intermembrane space to oxidative phosphorylation increases in the presence of macromolecules.
FEBS Lett
386:
255-259,
1996[ISI][Medline].
33.
Lawrence, CL,
Billups B,
Rodrigo GC,
and
Standen NB.
The KATP channel opener diazoxide protects cardiac myocytes during metabolic inhibition without causing mitochondrial depolarization or flavoprotein oxidation.
Br J Pharmacol
134:
535-542,
2001[ISI][Medline].
34.
Lee, AC,
Xu X,
Blachly-Dyson E,
Forte M,
and
Colombini M.
The role of yeast VDAC genes on the permeability of the mitochondrial outer membrane.
J Membr Biol
161:
173-181,
1998[ISI][Medline].
35.
Lemasters, JJ,
and
Hackenbrock CR.
Continuous measurement of adenosine triphosphate with firefly luciferase luminescence.
Methods Enzymol
56:
530-544,
1979[Medline].
36.
Liu, Y,
Sato T,
O'Rourke B,
and
Marban E.
Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection?
Circulation
97:
2463-2469,
1998
37.
McPherson, CD,
Pierce GN,
and
Cole WC.
Ischemic cardioprotection by ATP-sensitive K+ channels involves high-energy phosphate preservation.
Am J Physiol Heart Circ Physiol
265:
H1809-H1818,
1993
38.
Mizumura, T,
Nithipatikom K,
and
Gross GJ.
Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs.
Circulation
92:
1236-1245,
1995
39.
Murata, M,
Akao M,
O'Rourke B,
and
Marban E.
Mitochondrial ATP-sensitive potassium channels attenuate matrix Ca2+ overload during simulated ischemia and reperfusion: possible mechanism of cardioprotection.
Circ Res
89:
891-898,
2001
40.
Murry, CE,
Richard VJ,
Reimer KA,
and
Jennings RB.
Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode.
Circ Res
66:
913-931,
1990
41.
Nakashima, RA,
and
Garlid KD.
Quinine inhibition of Na+ and K<